#United States #Washington #Medical Advisory Board #Cannabis Policy #NCCC

NCCC Forms Medical Advisory Board to Influence Cannabis Reforms

On June 4, 2026, the National Compassionate Care Council (NCCC) made a significant announcement regarding its Medical Advisory Board. This newly formed board is comprised of highly respected physicians and researchers specializing in cannabinoid medicine. Their primary focus is to provide scientific and clinical insights aimed at advancing evidence-based cannabis policy changes at both federal and state levels.

The Formation of the Advisory Board

The Medical Advisory Board brings together an elite group of medical professionals from various specialties, including emergency medicine, oncology, pain management, palliative care, and cannabinoid therapeutics. With their extensive experience in clinical care and research, these experts are well-positioned to address the complexities of cannabis policy reform. The board members include Dr. Leigh Vinocur, the NCCC’s Chief Medical Advisor, along with other notable figures from institutions such as Duke University and the University of Chicago.

Dr. Vinocur emphasized that for over fifty years, federal cannabis policies have been predominantly shaped by administrative hurdles rather than their therapeutic benefits. He stated, "Cannabis policy in Washington is finally beginning to move toward the kind of evidence-based, physician-guided approach that patients and clinicians have long advocated for." This marks a pivotal moment where the medically-driven perspective could influence future legislation.

A Focus on Evidence-Based Care

The advisory board aims to facilitate a seamless transition from clinical developments to legislative reforms by leveraging real-world evidence. Through a focus on standardized dosing and informed patient decision-making, board members are committed to advocating for policies that reflect the realities of patient care. Their collective experience and knowledge will play an essential role in addressing the existing gap between clinical practice and federal regulations.

Shawn Hauser, a partner at Vicente LLP and chair of the NCCC, responded to the urgency for reform by noting that the existing cannabis policy has lagged significantly behind scientific advancements. He remarked, "The cost of that gap has been borne by patients, veterans, researchers, and clinicians attempting to provide evidence-based care."

The Medical Advisory Board represents a hopeful advancement in closing this divide, as its formation reflects a growing consensus among medical professionals about the necessity for a more responsive cannabis policy.

About the National Compassionate Care Council

The NCCC is dedicated to updating the standards of care and closing the distance between outdated regulations and the immediate needs of patients. By prioritizing patient care over bureaucratic constraints, the council seeks to ensure safe, timely access to physician-guided cannabinoid therapies for individuals with urgent healthcare needs. They aim for a straightforward mission: more healing and less waiting.

For those interested in learning more about the NCCC and its initiatives, further information is available at compassionatecarecouncil.org where they can capture the essence of their mission and ongoing efforts toward reforming cannabis policy effectively.